aVaxziPen
aVaxziPen Ltd is a biotech company dedicated to transforming vaccine delivery through innovative, needle-free, solid-dose vaccine platforms. Their mission is to improve global health by providing thermostable, easy-to-administer vaccines that can reach underserved populations, reduce vaccine hesitancy, and eliminate cold chain requirements. They develop and commercialize proprietary vaccine formulations and delivery devices aimed at enhancing vaccine accessibility, safety, and cost-effectiveness.
Industries
Nr. of Employees
small (1-50)
aVaxziPen
Abingdon, Oxfordshire, United Kingdom, Europe
Products
Solid-dose vaccine microtablet
A sub-millimetre solid-dose vaccine unit produced by microtableting that dissolves after delivery and is formulated for enhanced thermostability and precise dosing.
Reusable pen applicator and disposable cartridge system
A pen-like applicator engineered to deliver solid-dose vaccine cartridges; applicator is reusable for multiple doses while cartridges are single-use and non-reusable by design.
Solid-dose vaccine microtablet
A sub-millimetre solid-dose vaccine unit produced by microtableting that dissolves after delivery and is formulated for enhanced thermostability and precise dosing.
Reusable pen applicator and disposable cartridge system
A pen-like applicator engineered to deliver solid-dose vaccine cartridges; applicator is reusable for multiple doses while cartridges are single-use and non-reusable by design.
Services
Preclinical stability and immunogenicity evaluation
Collaborative preclinical studies to evaluate thermostability, delivery and immunogenicity of vaccine candidates formulated as solid-dose units, including stability studies at multiple temperatures and in vivo immunogenicity testing.
GMP clinical‑trial manufacturing for sterile solid-dose products
Production of sterile solid-dose vaccine products on isolator-based manufacturing lines and process development from laboratory to GMP scale in preparation for human clinical trials.
Device development and human factors evaluation
Design and usability testing of a reusable pen applicator and single-use cartridges to enable needle-free delivery of solid-dose vaccines with minimal training.
Preclinical stability and immunogenicity evaluation
Collaborative preclinical studies to evaluate thermostability, delivery and immunogenicity of vaccine candidates formulated as solid-dose units, including stability studies at multiple temperatures and in vivo immunogenicity testing.
GMP clinical‑trial manufacturing for sterile solid-dose products
Production of sterile solid-dose vaccine products on isolator-based manufacturing lines and process development from laboratory to GMP scale in preparation for human clinical trials.
Device development and human factors evaluation
Design and usability testing of a reusable pen applicator and single-use cartridges to enable needle-free delivery of solid-dose vaccines with minimal training.
Expertise Areas
- Vaccine formulation and microtableting
- Needle-free delivery systems
- Thermostable vaccine development
- Preclinical immunogenicity and animal-model testing
Key Technologies
- Solid-dose microtableting
- Pen applicator delivery device
- Thermostable vaccine formulations
- Isolator-based sterile manufacturing